Log In
Get Started
Home
Watchlist
News
Signals
Picks
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.
Company
About Us
Careers
Blog
News
Help & Support
Help Center
Contact Us
Pro Support
Legal
Privacy Policy
Terms of Use
Instagram
YouTube
© 2024 Cashu PTY LTD.
Join our newsletter to keep up to date with us!
Sign Up
Signals
CRBP
Corbus Pharmaceuticals Holdings
24 days ago
Analysts think CRBP stock price could increase by 956%
51.68%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
about 2 months ago
CRBP beat EPS expectations by 39.57%
0.00%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
about 2 months ago
CRBP Dominic Smethurst sells $43K worth of shares
0.00%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
5 months ago
Analysts think CRBP stock price could increase by 265%
-29.55%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
5 months ago
Analysts think CRBP stock price could increase by 255%
-26.92%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
6 months ago
CRBP missed EPS expectations by 18.43%
0.00%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
6 months ago
Analysts think CRBP stock price could increase by 288%
-4.18%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
7 months ago
CRBP is now overvalued and could go down -50%
0.00%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
7 months ago
Analysts think CRBP stock price could increase by 278%
-9.43%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
7 months ago
CRBP Asset Management Cormorant LP buys $7.8M worth of shares
-22.30%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings
7 months ago
CRBP has been in the news 357% more than usual
-5.61%
📡️ Health Care
CRBP
Corbus Pharmaceuticals Holdings Inc
8 months ago
CRBP has been in the news 375% more than usual
-67.10%
📡️ Health Care
Stocks
Health Care
crbp
Add to Watchlist
Corbus Pharmaceuticals Holdings
CRBP
-0.27 (-3.60%)
7.23
USD
At close at Apr 29, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials